Gene Biotherapeutics, Inc. Accounts Payable
Gene Biotherapeutics, Inc. had Accounts Payable of $745.57 thousand as of 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2022-04-14
- 2020-12-31: Accounts Payable, Current $745.57K.
- 2020-09-30: Accounts Payable, Current $661.95K.
- 2020-06-30: Accounts Payable, Current $821.67K.
- 2020-03-31: Accounts Payable, Current $1.04M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2020-12-31 | $745.57K 10-K/A · filed 2022-04-14 | |
| 2020-09-30 | $661.95K 10-Q · filed 2021-10-27 | |
| 2020-06-30 | $821.67K 10-Q · filed 2021-09-17 | |
| 2020-03-31 | $1.04M 10-Q · filed 2021-09-03 | |
| 2019-12-31 | $967.13K 10-K/A · filed 2022-04-14 | |
| 2018-12-31 | $1.86M 10-K · filed 2021-04-23 | |
| 2017-12-31 | $1.87M 10-K · filed 2021-04-23 | |
| 2017-03-31 | $1.61M 10-Q · filed 2017-07-28 | |
| 2016-12-31 | $1.67M 10-K · filed 2017-07-28 | |
| 2016-09-30 | $1.52M 10-Q · filed 2017-03-21 | |
| 2016-06-30 | $1.89M 10-Q · filed 2017-03-06 | |
| 2016-03-31 | $1.76M 10-Q · filed 2017-03-01 | |
| 2015-12-31 | $1.79M 10-K · filed 2017-07-28 | |
| 2015-09-30 | $1.62M 10-Q · filed 2016-10-27 | |
| 2015-06-30 | $1.52M 10-Q · filed 2016-08-29 | |
| 2015-03-31 | $1.35M 10-Q · filed 2015-06-18 | |
| 2014-12-31 | $1.20M 10-K · filed 2016-12-29 | |
| 2014-09-30 | $1.07M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $1.06M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $1.10M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $990.28K 10-K · filed 2015-05-22 | |
| 2013-09-30 | $802.37K 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $723.75K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $667.90K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $374.13K 10-K · filed 2014-04-15 | $777.86K 10-K · filed 2013-04-05 |
| 2012-09-30 | $491.25K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $638.98K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.19M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $749.59K 10-K · filed 2013-04-05 | |
| 2011-09-30 | $446.74K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $632.07K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $597.87K 10-K · filed 2012-03-30 |